SEC Form 4 · accession 0001140361-15-003906
PLUS THERAPEUTICS, INC. · CNSY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tiago Girao
Officer — VP & Chief Financial Officer
Period of report
Jan 30, 2015
Accepted (ET)
Feb 3, 2015 · 7:28 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001095981
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 60,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock OptionF1 | $0.48 | Jan 30, 2015 | A | 120,000 | A | Feb 28, 2015 | Jan 30, 2025 | Common Stock | 120,000 | 270,000 | D |
Explanation of responses
- F1The Employee Stock options vest 1/48th each month from date of grant, subject to remaining an employee of the Company.